Gasparotto Venusia, Castagliuolo Ignazio, Chiarelotto Gianfranco, Pezzi Vincenzo, Montanaro Daniela, Brun Paola, Palù Giorgio, Viola Giampietro, Ferlin Maria Grazia
Department of Pharmaceutical Sciences, University of Padova, 35131 Padova, Italy.
J Med Chem. 2006 Mar 23;49(6):1910-5. doi: 10.1021/jm0510676.
The newly synthesized 7-phenyl-3H-pyrrolo[3,2-f]quinolinones 16-26 and previously 27 and 28 were assayed for their in vitro antiproliferative activity on tumor cell lines, and the lead compound 16 in vivo on a singenic hepatocellular carcinoma in Balb/c mice. Results from FACS, immunofluorescence microscopy analysis, tubulin polymerization assay, and tritiated water release assay for the CYP19 activity confirmed the new compounds as potential anticancer agents acting by tubulin depolymerization, but devoid of aromatase activity unlike their geometric [2,3-h] isomers.
对新合成的7-苯基-3H-吡咯并[3,2-f]喹啉酮16 - 26以及之前的27和28进行了体外对肿瘤细胞系的抗增殖活性测定,并对先导化合物16在Balb/c小鼠的单基因肝细胞癌上进行了体内试验。来自流式细胞术、免疫荧光显微镜分析、微管蛋白聚合测定以及用于CYP19活性的氚化水释放测定的结果证实,这些新化合物是通过微管蛋白解聚起作用的潜在抗癌剂,但与它们的几何[2,3-h]异构体不同,它们没有芳香化酶活性。